NCT07419828: A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease
- State
- Under way
- Phase
- Phase 3
- People
- 5,386 planned
- Started
- 13 Mar 2026
- Primary completion
- Apr 2030
- Arms
- HRS-1780 tablets
- Results
- None posted
- 19 Feb 2026: Trial registered
- 13 Mar 2026: Trial started